Thumbnail 1568534
thumbnail
Large (256x256)

Articles

UK firm GSK to pay $2.2bn over Zantac cancer claims
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.
UK firm GSK to pay $2.2bn over Zantac cancer claims
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.
1